Physician profile
John C Redfern
NPI 1023211794
$3,649.22
in general payments reported to CMS, 2019-2025
11 companies · $2,346 in 2025
The $2,346 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $165 · 2021: $293 · 2022: $307 · 2023: $158 · 2024: $229 · 2025: $2,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,795 · Travel and Lodging: $914 · Gift: $23.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,795.47 |
| Travel and Lodging | $913.72 |
| Gift | $23.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shoulder Innovations, INC. | $1,723.04 | 2025 | Inset System |
| Stryker Corporation | $1,512.37 | 2019-2025 | Accolade, Aequalis Reversed II, Triathlon |
| Zimmer Biomet Holdings, INC. | $137.68 | 2021 | |
| Alliance Medical | $120.08 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $44.37 | 2024 | Zilretta, Exparel, Iovera |
| Si-Bone, INC. | $34.48 | 2019 | |
| Vericel Corporation | $18.25 | 2025 | Maci |
| Abbott Laboratories | $16.90 | 2022 | |
| Smith+Nephew, INC. | $14.79 | 2023 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Spatial Frame |
| Boston Scientific Corporation | $14.29 | 2021 | |
| Gemini Mountain Medical, LLC | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Redfern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.